Rare Kidney Stone Consortium Biobank

NCT02026388 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-07-22

No results posted yet for this study

Summary

This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent disease, and from their family members, for use in future research.

Conditions

  • Primary Hyperoxaluria
  • Dent Disease
  • APRT Deficiency
  • Cystinuria

Sponsors & Collaborators

Principal Investigators

  • John C Lieske, M.D. · Mayo Clinic

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2030-06-30
Completion
2030-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02026388 on ClinicalTrials.gov